Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): Theoretical basis and practical examples.

Autoria(s): Dokoumetzidis, Aristeidis
Data(s)

01/09/2008
Identificador

http://pure.qub.ac.uk/portal/en/publications/biopharmaceutics-classification-systems-for-new-molecular-entities-bcsnmes-and-marketed-drugs-bcsmd-theoretical-basis-and-practical-examples(41179020-330a-4d9b-9a92-3d4439d9dd9b).html

http://dx.doi.org/10.1016/j.ijpharm.2008.05.021

http://www.scopus.com/inward/record.url?scp=47949129181&partnerID=8YFLogxK
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Dokoumetzidis , A 2008 , ' Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): Theoretical basis and practical examples. ' International Journal of Pharmaceutics , vol 361(1-2) , no. 1-2 , pp. 70-77 . DOI: 10.1016/j.ijpharm.2008.05.021
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/3000/3003 #Pharmaceutical Science
Tipo

article
Acesso ao item digital